Finance

Lists
600161:SHA
Beijing Tiantan Biological Products Corp
CNÂ¥12.73
+1.43%
(+0.18) 1D
Oct 9, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600161...
Open
CNÂ¥12.51
High
CNÂ¥12.86
Low
CNÂ¥12.51
Mkt. cap
24.82B
Avg. vol.
12.59M
Volume
18.80M
Dividend
1.18%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Sep 23, 2026
P/E ratio
33.24
52-wk high
CNÂ¥19.38
52-wk low
CNÂ¥11.12
EPS
CNÂ¥0.38
Shares outstanding
871.14M
No. of employees
5K
Open
CNÂ¥12.51
High
CNÂ¥12.86
Low
CNÂ¥12.51
Mkt. cap
24.82B
Avg. vol.
12.59M
Volume
18.80M
Dividend
1.18%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Sep 23, 2026
P/E ratio
33.24
52-wk high
CNÂ¥19.38
52-wk low
CNÂ¥11.12
EPS
CNÂ¥0.38
Shares outstanding
871.14M
No. of employees
5K
News stories
From web sources and news partners
About Beijing Tiantan Biological Products Corp
CEO-
Employees5.2K
Founded1966
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.35B
1.70B
1.14B
1.45B
Cost of goods sold
803.48M
981.89M
746.78M
931.07M
Cost of revenue
803.48M
981.89M
746.78M
931.07M
Research and development expenses
46.23M
56.84M
39.19M
32.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
158.23M
164.29M
139.41M
157.08M
Operating expense
223.23M
268.36M
174.79M
250.41M
Total operating expenses
1.03B
1.25B
921.56M
1.18B
Operating income
327.97M
452.71M
220.14M
272.18M
Other non operating income
-5.26M
3.10M
-860.04K
2.19M
EBT including unusual items
309.03M
475.33M
223.22M
297.63M
EBT excluding unusual items
325.86M
459.76M
225.12M
277.19M
Income tax expense
54.37M
105.90M
44.12M
62.16M
Effective tax rate
17.59%
22.28%
19.77%
20.89%
Other operating expenses
-8.80M
43.92M
1.49M
46.85M
Net income
186.12M
272.15M
125.87M
173.04M
Net profit margin
13.74%
15.98%
11.02%
11.90%
Earnings per share
0.10
0.13
0.06
0.08
Interest and investment income
6.38M
3.98M
7.68M
4.71M
Interest expense
-3.23M
-
-1.84M
-1.87M
Net interest expenses
3.15M
3.98M
5.84M
2.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
404.25M
552.44M
319.87M
378.43M
Gain or loss from assets sale
204.68K
-104.45K
-
-21.40K
AI content may include mistakes. Learn more
Google apps